Pepbase

Legality Guide

A comprehensive overview of the global legal status, regulatory context, and compliance information for PT-141.

PT-141, also known as Bremelanotide, is FDA-approved for treating hypoactive sexual desire disorder (HSDD) in premenopausal women under the brand name Vyleesi [Doc 2]. It is not approved for use in men but is prescribed off-label for erectile dysfunction [Doc 3]. PT-141 is legally available with a prescription, and its market presence is regulated [Doc 2].

fda approval

PT-141 is FDA-approved as Vyleesi for HSDD in premenopausal women since June 2019 [Doc 2]. It was developed by Palatin Technologies and is administered via subcutaneous injection [Doc 3]. Although not officially approved for men, it is used off-label for erectile dysfunction [Doc 3]. The FDA approval confirms its safety and efficacy for the specified use [Doc 2].

research chemical loophole

PT-141 is also sold as a research chemical, which creates a legal gray area for non-prescription use [Doc 1]. Vendors market it as 'not for human consumption' to bypass direct FDA regulation [Doc 1]. While legal to purchase for research, selling it for human use without a prescription is illegal [Doc 1]. Customs may seize shipments if labeled incorrectly [Doc 1].

global legal status

PT-141's legal status varies globally. In the US, it is FDA-approved for specific use [Doc 2]. In the EU, it is under review for potential approval [Doc 2]. In other jurisdictions, it may be available through prescription or as a research chemical, subject to local regulations [Doc 2].

purchasing and possession

PT-141 can be legally purchased with a prescription as Vyleesi [Doc 2]. As a research chemical, it is available online but must be labeled 'not for human consumption' [Doc 1]. Possession for personal use is generally tolerated, but selling it for human use without approval is illegal [Doc 1].

enforcement realities

The FDA focuses enforcement on vendors making unapproved medical claims [Doc 1]. Individuals purchasing PT-141 for personal use face minimal legal risk [Doc 1]. However, selling it as a treatment without approval can lead to legal action [Doc 1].

Global Legal Status

JurisdictionLegal Status
USFDA Approved for HSDD in Women, Off-label Use in Men
EUUnder Review for Approval

Frequently Asked Questions

Is PT-141 FDA approved?
Yes, PT-141 is FDA-approved as Vyleesi for treating hypoactive sexual desire disorder in premenopausal women [Doc 2].
Is it legal to buy PT-141 online?
Yes, PT-141 can be purchased online as a research chemical, but it is illegal to sell it for human use without a prescription [Doc 1].
Is PT-141 a controlled substance?
No, PT-141 is not classified as a controlled substance, but it is regulated as a prescription medication for specific uses [Doc 2].
Will PT-141 show up on a drug test?
PT-141 is not typically screened for in standard drug tests, as it is not a controlled substance [Doc 2].
Did the FDA ban PT-141 from compounding pharmacies?
No, PT-141 is FDA-approved as Vyleesi and is available through prescription, not banned from compounding pharmacies [Doc 2].
Can PT-141 be used for erectile dysfunction?
While not FDA-approved for erectile dysfunction, PT-141 is prescribed off-label for this condition, particularly in men unresponsive to PDE5 inhibitors [Doc 3].
What is the mechanism of action for PT-141?
PT-141 works by activating melanocortin receptors in the brain, enhancing sexual desire and arousal through central nervous system pathways [Doc 2].